Current filters:


Popular Filters

1176 to 1200 of 1237 results

Navamedic on track to launch eight generics; sales rise 43%


Norwegian drugmaker Navamedic ASA (OSE: NAVA) says sales in the second quarter of 2011 were record high…

FinancialGenericsMarkets & MarketingNavamedic

Google in $500 million settlement with DoJ over unlicensed drug ads


On-line search engine Google Inc has agreed to forfeit $500 million for allowing on-line Canadian pharmacies…

GenericsLegalMarkets & MarketingNorth AmericaPharmaceutical

Jordan’s Hikma delivers 10.4% sales growth in first half 2011


Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) has reported interim results for the six months…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Par Pharma to acquire niche generics producer Anchen for $410 million


Par Pharmaceutical (NYSE: PRX) has entered into a definitive agreement to acquire fellow USA-based Anchen…

Anchen PharmaceuticalsGenericsMergers & AcquisitionsPar Pharmaceuticals

Spain hopes to save 2.4 billion euros by ordering doctors to Rx generics


As part of moves to reduce the nation’s budget deficit, Spain’s socialist government has passed…


UAE pharmaceutical industry set to benefit from lifestyle changes


A recent Dubai Chamber of Commerce and Industry study indicates that the United Arab Emirates (UAE) pharmaceutical…

GenericsHealthcareMarkets & MarketingPharmaceuticalRest of the World

Changing the mood of Brazilian antidepressant market; fake Levitra


The Vice President of Brazil’s Superior Court of Justice (STJ), Minister Felix Fischer, has restored…

BayerGenericsLevitraLexaproLundbeckNeurologicalPharmaceuticalRegulationReproductiveSouth America

IMS debuts MIDAS Biosimilars, a new market tool for fast-developing pharma segment


IMS Health has launched IMS MIDAS Biosimilars, a market measurement tool that enables clients to assess…

BiotechnologyGenericsGlobalMarkets & Marketing

Australia’s generics firms also welcome Senate report on government administration of the PBS


Following the release of the Australia’s Senate Finance and Administration References Committee…


Intellipharmaceutics and Par Pharma expand Focalin accord


Canada’s Intellipharmaceutics International (TSX:I) and US generic drugmaker Par Pharmaceuticals…

Focalin XRGenericsIntellipharmaceuticsLicensingNeurologicalPar Pharmaceuticals

Call for IP protection norms for manufacturing generic drugs in India


India’s Department of Commerce has called for coordination among various ministries for a consensus…


Endo Pharma sues Mylan over Frova patent infringement


US generic drugmaker Mylan (Nasdaq: MYL) yesterday confirmed that the company and its subsidiary Mylan…

Endo PharmaceuticalsFrovaFrovatriptan SuccinateGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaRegulation

Drug shortages in USA leading to price gouging, possible safety issues


As health care providers in the USA deal with record rates of drug shortages, some “gray market"…

GenericsHealthcareMarkets & MarketingNorth AmericaPharmaceuticalPricing

Pfizer wins case to stop Teva selling generic Viagra in USA


Global pharmaceutical behemoth Pfizer (NYSE: PFE) revealed yesterday that it has prevailed in its patent…

GenericsLegalNorth AmericaPatentsPfizerPharmaceuticalReproductiveTeva Pharmaceutical IndustriesViagra

Pharma contract manufacturing revenues to reach $64.07 billion in 2016, says Visiongain


The global contract manufacturing sector will generate revenues of $64.07 billion in 2016, according…

GenericsGlobalMarkets & MarketingPharmaceutical

South Korea to cut pharma prices by average 17% to save $1.94 billion


In a move that is likely to curb current growth prospects for the pharmaceutical industry in South Korea,…


Good first-half results from Stada Arz driven by branded and generic drugs


German drugmaker Stada Arzneimittel reported first-half 2011 results with 7% growth in group sales to…

FinancialGenericsPharmaceuticalSTADA Arzneimittel

Tentative OK from US FDA for Watson's rosuvastatin zinc tablets


US drugmaker Watson Pharmaceuticals (NYSE: WPI) says that its subsidiary, Watson Laboratories, has received…

AstraZenecaCardio-vascularCrestorGenericsNorth AmericaRegulationrosuvastatinWatson Pharmaceuticals

Generic penetration of Japanese pharma likely to fall short of 2012 government target


Innovation is the sole driver for Japanese pharma in the short-term, according to Global Biopharma Outlook…

Asia-PacificGenericsMarkets & MarketingPharmaceutical

US payers will want more info on biosimilars than FDA may accept for approval, survey finds


To feel comfortable with biosimilars, US payers survey by advisory firm Decision Resources indicate they…

BiotechnologyGenericsNorth AmericaRegulationResearch

Ranbaxy posts 2nd-qtr 2011 net profit down 25%


India’s largest drugmaker Ranbaxy (RANB: BO) reported second-quarter 2011 financial results, with…

Daiichi SankyoFinancialGenericsRanbaxy Laboratories

1176 to 1200 of 1237 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top